$ORC
Orchid Island Capital, Inc. Stock $orc

$orc Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-K Financial Statement

#000151862121000030 Filed on February 26, 2021

Income Statement

Concept	2021 Q1	2020 Q4	2020 Q3
Revenue	$26.86M	$21.29M	$27.22M
YoY Change	-24.71%	-48.54%	-24.18%
Cost Of Revenue	$3.560M	$3.400M	$3.300M
YoY Change	-80.11%	-84.19%	-86.11%
Gross Profit	-$27.50M	$17.89M	$29.67M
YoY Change	-69.59%	-9.96%	-507.0%
Gross Profit Margin	-102.4%	84.03%	108.99%
Selling, General & Admin	$3.493M	$1.210M	$2.849M
YoY Change	63.15%	15.24%	8.24%
% of Gross Profit		6.76%	9.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$3.493M	$1.410M	$2.849M
YoY Change	63.15%	11.9%	8.24%
Operating Profit	-$30.99M	$16.48M	$26.82M
YoY Change	-66.52%	-11.45%	-370.32%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		$972.0K	$1.220M
YoY Change		10.45%	45.07%
Pretax Income	-$29.37M	$16.48M	$28.08M
YoY Change	-67.8%	-11.45%	-431.13%
Income Tax
% Of Pretax Income
Net Earnings	-$29.37M	$16.48M	$28.08M
YoY Change	-67.8%	-11.46%	-431.2%
Net Earnings / Revenue	-109.36%	77.4%	103.13%
Basic Earnings Per Share	-$0.34		$0.42
Diluted Earnings Per Share	-$0.34	$0.23	$0.42
COMMON SHARES
Basic Shares Outstanding	85.12M shares	69.30M shares	66.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q1	2020 Q4	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$211.4M	$220.1M	$199.8M
YoY Change	29.93%	13.57%	35.55%
Cash & Equivalents	$211.4M	$220.1M	$199.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$155.0M	$400.0K	$0.00
Other Receivables	$10.80M	$9.700M	$10.40M
Total Short-Term Assets	$377.2M	$230.2M	$210.2M
YoY Change	118.29%	11.64%	-43.69%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$4.339B	$3.727B	$3.540B
YoY Change	47.13%	3.79%	-7.34%
Other Assets	$117.2M	$58.80M	$47.50M
YoY Change	427.93%	-10.77%	75.28%
Total Long-Term Assets	$4.554B	$3.828B	$3.603B
YoY Change	52.32%	4.13%	-7.15%
TOTAL ASSETS
Total Short-Term Assets	$377.2M	$230.2M	$210.2M
Total Long-Term Assets	$4.554B	$3.828B	$3.603B
Total Assets	$4.931B	$4.058B	$3.813B
YoY Change	55.92%	4.53%	-10.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$700.0K	$600.0K	$600.0K
YoY Change	40.0%	0.0%	0.0%
Accrued Expenses	$900.0K	$1.200M	$800.0K
YoY Change	-76.32%	-89.19%	-93.28%
Deferred Revenue
YoY Change
Short-Term Debt	$4.182B	$3.596B	$3.281B
YoY Change	48.8%	4.28%	-13.97%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.407B	$3.602B	$3.401B
YoY Change	56.1%	3.97%	-11.24%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$57.40M	$40.40M	$35.40M
YoY Change	85.76%	86.18%	18.79%
Total Long-Term Liabilities	$57.40M	$40.40M	$35.40M
YoY Change	85.76%	86.18%	18.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.407B	$3.602B	$3.401B
Total Long-Term Liabilities	$57.40M	$40.40M	$35.40M
Total Liabilities	$4.465B	$3.643B	$3.436B
YoY Change	56.42%	4.48%	-11.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$47.36M	-$17.99M	-$34.47M
YoY Change	-57.45%	-10.58%	-11.0%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$466.2M	$415.3M	$376.7M
YoY Change
Total Liabilities & Shareholders Equity	$4.931B	$4.058B	$3.813B
YoY Change	55.92%	4.53%	-10.35%

Cashflow Statement

Concept	2021 Q1	2020 Q4	2020 Q3
OPERATING ACTIVITIES
Net Income	-$29.37M	$16.48M	$28.08M
YoY Change	-67.8%	-11.46%	-431.2%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$24.76M	$24.49M	$18.82M
YoY Change	-448.77%	2.99%	113.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$662.4M	-$309.1M	-$117.6M
YoY Change	-217.5%	-171.27%	-77.11%
Cash From Investing Activities	-$662.4M	-$309.1M	-$117.6M
YoY Change	-217.5%	-171.27%	-77.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$96.61M
YoY Change	396.79%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$666.7M	336.8M	110.1M
YoY Change	-205.18%	-188.38%	-79.07%
NET CHANGE
Cash From Operating Activities	$24.76M	24.49M	18.82M
Cash From Investing Activities	-$662.4M	-309.1M	-117.6M
Cash From Financing Activities	$666.7M	336.8M	110.1M
Net Change In Cash	$29.09M	52.16M	11.32M
YoY Change	-104.59%	-31.76%	-46.4%
FREE CASH FLOW
Cash From Operating Activities	$24.76M	$24.49M	$18.82M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2018	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	4052000	USD
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001518621
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-58891000	USD
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-45207000	USD
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.79
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Entity File Number EntityFileNumber	001-35236
CY2020	dei	Entity Registrant Name EntityRegistrantName	Orchid Island Capital, Inc.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-3269228
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	3305 Flamingo Drive
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Vero Beach
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32963
CY2020	dei	City Area Code CityAreaCode	772
CY2020	dei	Local Phone Number LocalPhoneNumber	231-1400
CY2020	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2020	dei	Trading Symbol TradingSymbol	ORC
CY2020	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q2	dei	Entity Public Float EntityPublicFloat	298895633	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	85121365	shares
CY2020Q4	us-gaap	Financial Instruments Owned And Pledged As Collateral At Fair Value FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue	3719906000	USD
CY2019Q4	us-gaap	Financial Instruments Owned And Pledged As Collateral At Fair Value FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue	3584354000	USD
CY2020Q4	us-gaap	Financial Instruments Owned And Not Pledged At Fair Value FinancialInstrumentsOwnedAndNotPledgedAtFairValue	6989000	USD
CY2019Q4	us-gaap	Financial Instruments Owned And Not Pledged At Fair Value FinancialInstrumentsOwnedAndNotPledgedAtFairValue	6567000	USD
CY2019Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	3590921000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220143000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	193770000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	79363000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	84885000	USD
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	9721000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20122000	USD
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63061781	shares
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17994000	USD
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	76073317	shares
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1157000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	432524000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	24311000	USD
CY2019	orc	Net Portfolio Income NetPortfolioIncome	34650000	USD
CY2018	orc	Net Portfolio Income NetPortfolioIncome	-32425000	USD
CY2019Q4	us-gaap	Interest Receivable InterestReceivable	12404000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	20999000	USD
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	0	USD
CY2020Q4	us-gaap	Other Receivables From Broker Dealers And Clearing Organizations OtherReceivablesFromBrokerDealersAndClearingOrganizations	414000	USD
CY2019Q4	us-gaap	Other Receivables From Broker Dealers And Clearing Organizations OtherReceivablesFromBrokerDealersAndClearingOrganizations	0	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	516000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	100000	USD
CY2020Q4	us-gaap	Assets Assets	4058051000	USD
CY2019Q4	us-gaap	Assets Assets	3882080000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	3595586000	USD
CY2020Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	4970000	USD
CY2019Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	5045000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	33227000	USD
CY2019Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	20658000	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	632000	USD
CY2019Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	622000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	1041000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	3642760000	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	631000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	414998000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	395507000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4058051000	USD
CY2020	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	116045000	USD
CY2019	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	142324000	USD
CY2018	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	154581000	USD
CY2020	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	25056000	USD
CY2019	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	83666000	USD
CY2018	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	70360000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	58658000	USD
CY2018	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	84221000	USD
CY2020	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-24986000	USD
CY2019	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-10877000	USD
CY2018	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-30289000	USD
CY2020	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	25761000	USD
CY2019	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	38045000	USD
CY2018	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-110668000	USD
CY2020	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-79092000	USD
CY2019	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-51176000	USD
CY2019	us-gaap	Management Fee Expense ManagementFeeExpense	5528000	USD
CY2018	us-gaap	Management Fee Expense ManagementFeeExpense	6204000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	1514000	USD
CY2020	us-gaap	Management Fee Expense ManagementFeeExpense	5281000	USD
CY2020Q4	orc	Net Amount Of Liabilities NetAmountOfLiabilities	5452000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	1380000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	1567000	USD
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	38000	USD
CY2019	us-gaap	Labor And Related Expense LaborAndRelatedExpense	115000	USD
CY2018	us-gaap	Labor And Related Expense LaborAndRelatedExpense	407000	USD
CY2020	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	998000	USD
CY2019	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	998000	USD
CY2020	us-gaap	Professional Fees ProfessionalFees	1045000	USD
CY2019	us-gaap	Professional Fees ProfessionalFees	1105000	USD
CY2018	us-gaap	Professional Fees ProfessionalFees	851000	USD
CY2020	orc	Direct Reit Operating Expenses DirectReitOperatingExpenses	1057000	USD
CY2019	orc	Direct Reit Operating Expenses DirectReitOperatingExpenses	997000	USD
CY2018	orc	Direct Reit Operating Expenses DirectReitOperatingExpenses	1631000	USD
CY2020	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	611000	USD
CY2019	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	262000	USD
CY2018	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	334000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10544000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10385000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11962000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	2128000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	24265000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-44387000	USD
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.03
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.43
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.85
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	67210815	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56328027	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	52198175	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53062000	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	462211000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-44387000	USD
CY2018	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	55814000	USD
CY2018	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	49000	shares
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	492000	USD
CY2018	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	3979000	shares
CY2018	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-26423000	USD
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49132000	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	336079000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	24265000	USD
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	54421000	USD
CY2019	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	14377000	shares
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	92314000	USD
CY2019	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	23000	shares
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	294000	USD
CY2019	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	470000	shares
CY2019	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-3024000	USD
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63062000	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	395507000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	2128000	USD
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	53570000	USD
CY2020	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	13019000	shares
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	71050000	USD
CY2020	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	12000	shares
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	244000	USD
CY2020	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	20000	shares
CY2018	us-gaap	Profit Loss ProfitLoss	-44387000	USD
CY2020	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	244000	USD
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-68000	USD
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76073000	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	415291000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	2128000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	24265000	USD
CY2018	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-143000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	55374000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48161000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	94000000	USD
CY2019	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	294000	USD
CY2018	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	492000	USD
CY2020	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	775000	USD
CY2019	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	27168000	USD
CY2018	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	-140957000	USD
CY2020	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-2683000	USD
CY2019	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-837000	USD
CY2018	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-1203000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	446000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-80000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3000	USD
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-9944000	USD
CY2019	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	4656000	USD
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	2583000	USD
CY2019	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	22000	USD
CY2018	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	4000	USD
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	10000	USD
CY2019	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-32000	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4859434000	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4241822000	USD
CY2018	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3893828000	USD
CY2020	orc	Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading	4200536000	USD
CY2019	orc	Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading	3321206000	USD
CY2018	orc	Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading	3885817000	USD
CY2020	orc	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading	523699000	USD
CY2019	orc	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading	594833000	USD
CY2018	orc	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading	373934000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	139807000	USD
CY2019	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2018	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	139712000	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2018	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2020	us-gaap	Proceeds From Payments For Securities Purchased Under Agreements To Resell ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell	30000	USD
CY2019	us-gaap	Proceeds From Payments For Securities Purchased Under Agreements To Resell ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell	0	USD
CY2018	us-gaap	Proceeds From Payments For Securities Purchased Under Agreements To Resell ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell	0	USD
CY2020	orc	Proceeds From Net Tba Settlements ProceedsFromNetTbaSettlements	-881000	USD
CY2018	orc	Proceeds From Net Tba Settlements ProceedsFromNetTbaSettlements	7292000	USD
CY2020	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	63195000	USD
CY2019	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	20600000	USD
CY2018	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-6805000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-199340000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-354806000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	380020000	USD
CY2020	orc	Proceeds From Securities Sold Under Agreements To Repurchase ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase	33140625000	USD
CY2019	orc	Proceeds From Securities Sold Under Agreements To Repurchase ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase	45595010000	USD
CY2018	orc	Proceeds From Securities Sold Under Agreements To Repurchase ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase	52096292000	USD
CY2020	orc	Payments For Securities Sold Under Agreements To Repurchase PaymentsForSecuritiesSoldUnderAgreementsToRepurchase	32993145000	USD
CY2019	orc	Payments For Securities Sold Under Agreements To Repurchase PaymentsForSecuritiesSoldUnderAgreementsToRepurchase	45171956000	USD
CY2018	orc	Payments For Securities Sold Under Agreements To Repurchase PaymentsForSecuritiesSoldUnderAgreementsToRepurchase	52605026000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126263000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	35000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	79010000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	70431000	USD
CY2020Q4	orc	Securities Sold Settled In Later Period SecuritiesSoldSettledInLaterPeriod	0	USD
CY2019Q4	orc	Securities Sold Settled In Later Period SecuritiesSoldSettledInLaterPeriod	0	USD
CY2018Q4	orc	Securities Sold Settled In Later Period SecuritiesSoldSettledInLaterPeriod	220655000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	53645000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	53307000	USD
CY2018	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	59312000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	71050000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	92314000	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	68000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3024000	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	26423000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	164817000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	459037000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-594469000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	20851000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	152392000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-120449000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	278655000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126263000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246712000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	299506000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	278655000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<span style="font-family: 'Arial Narrow', 'sans-serif'; font-size: 11.00pt; letter-spacing: -0.10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The significant estimates affecting the accompanying financial statements are the fair values of RMBS and derivatives.</span><span style="font-family: 'Arial Narrow', 'sans-serif'; font-size: 11.00pt"> </span><span style="font-family: 'Arial Narrow', 'sans-serif'; font-size: 11.00pt; letter-spacing: -0.10pt">Management believes the estimates and assumptions underlying the financial statements are reasonable based on the information available as of December 31, 2020; however, uncertainty over the ultimate impact that COVID-19 will have on the global economy generally, and on Orchid’s business in particular, makes any estimates and assumptions as of December 31, 2020 inherently less certain than they would beabsent the current and potential impacts of COVID-19.</span>
CY2019Q4	orc	Gross Amounts Of Cash Posted Not Offset In Balance Sheet GrossAmountsOfCashPostedNotOffsetInBalanceSheet	-83547000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220143000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	193770000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	79363000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	84885000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	299506000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	278655000	USD
CY2020Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	3726895000	USD
CY2019Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	3590921000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Fair Value Of Collateral SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral	3729543000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	3595586000	USD
CY2020Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0023	pure
CY2019Q4	us-gaap	Securities Sold Under Agreements To Repurchase Fair Value Of Collateral SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral	3596721000	USD
CY2019Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	3448106000	USD
CY2019Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0203	pure
CY2020	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-79092000	USD
CY2019	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-51176000	USD
CY2018	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	24311000	USD
CY2020Q4	orc	Assets Pledged To Counterparties AssetsPledgedToCounterparties	3808905000	USD
CY2019Q4	orc	Assets Pledged To Counterparties AssetsPledgedToCounterparties	3681606000	USD
CY2020Q4	orc	Securities Pledged By Counterparties SecuritiesPledgedByCounterparties	6456000	USD
CY2019Q4	orc	Securities Pledged By Counterparties SecuritiesPledgedByCounterparties	1418000	USD
CY2020Q4	orc	Gross Amount Of Recognized Assets GrossAmountOfRecognizedAssets	20999000	USD
CY2020Q4	orc	Gross Amount Of Assets Offset In The Balance Sheet GrossAmountOfAssetsOffsetInTheBalanceSheet	0	USD
CY2020Q4	orc	Net Amount Of Assets Presented In The Balance Sheet NetAmountOfAssetsPresentedInTheBalanceSheet	20999000	USD
CY2020Q4	orc	Gross Amounts Of Financial Instruments Received Not Offset In Balance Sheet GrossAmountsOfFinancialInstrumentsReceivedNotOffsetInBalanceSheet	0	USD
CY2020Q4	orc	Gross Amounts Of Cash Collateral Received Not Offset In Balance Sheet GrossAmountsOfCashCollateralReceivedNotOffsetInBalanceSheet	-6083000	USD
CY2020Q4	orc	Net Amount Of Assets NetAmountOfAssets	14916000	USD
CY2020Q4	orc	Net Amount Of Liabilities Presented In The Balance Sheet NetAmountOfLiabilitiesPresentedInTheBalanceSheet	3628813000	USD
CY2020Q4	orc	Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet	-3536757000	USD
CY2019Q4	orc	Gross Amount Of Recognized Liabilties GrossAmountOfRecognizedLiabilties	3468764000	USD
CY2019Q4	orc	Gross Amount Of Liabilties Offset In The Balance Sheet GrossAmountOfLiabiltiesOffsetInTheBalanceSheet	0	USD
CY2019Q4	orc	Net Amount Of Liabilities Presented In The Balance Sheet NetAmountOfLiabilitiesPresentedInTheBalanceSheet	3468764000	USD
CY2019Q4	orc	Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet	-3382255000	USD
CY2019Q4	orc	Net Amount Of Liabilities NetAmountOfLiabilities	2962000	USD
CY2020	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	13019240	shares
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	71050000	USD
CY2019	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	14377126	shares
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	92314000	USD
CY2020	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	19891	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.10	pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	4000000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	56000	shares
CY2018	orc	Unvested Dividend Eligible Shares Outstanding Earnings Per Share UnvestedDividendEligibleSharesOutstandingEarningsPerShare	0	shares
CY2020	orc	Effect Of Weighting EffectOfWeighting	-8958000	shares
CY2019	orc	Effect Of Weighting EffectOfWeighting	-6797000	shares
CY2018	orc	Effect Of Weighting EffectOfWeighting	3066000	shares
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	67211000	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56328000	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	52198000	shares
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.03
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.43
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.85
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2128000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44387000	USD
CY2019	orc	Common Shares Outstanding Earnings Per Share CommonSharesOutstandingEarningsPerShare	63062000	shares
CY2018	orc	Common Shares Outstanding Earnings Per Share CommonSharesOutstandingEarningsPerShare	49132000	shares
CY2019	orc	Unvested Dividend Eligible Shares Outstanding Earnings Per Share UnvestedDividendEligibleSharesOutstandingEarningsPerShare	63000	shares
CY2020Q1	orc	Realized And Unrealized Gains RealizedAndUnrealizedGains	-108206000	USD
CY2020Q2	orc	Realized And Unrealized Gains RealizedAndUnrealizedGains	28749000	USD
CY2020Q3	orc	Realized And Unrealized Gains RealizedAndUnrealizedGains	5745000	USD
CY2020Q4	orc	Realized And Unrealized Gains RealizedAndUnrealizedGains	-4605000	USD
CY2020Q1	orc	Portfolio Income PortfolioIncome	-89058000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	64590000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	66310000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	67302000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	70497000	shares
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.240
CY2020Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.165
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.190
CY2020Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.195
CY2019Q1	orc	Interest Income InterestIncome	32433000	USD
CY2020Q1	orc	Interest Income InterestIncome	35671000	USD
CY2020Q2	orc	Interest Income InterestIncome	27258000	USD
CY2020Q3	orc	Interest Income InterestIncome	27223000	USD
CY2020Q1	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	16523000	USD
CY2020Q2	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	4479000	USD
CY2020Q3	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	2043000	USD
CY2020Q4	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	2011000	USD
CY2020Q1	orc	Net Interest Income NetInterestIncome	19148000	USD
CY2020Q3	orc	Net Interest Income NetInterestIncome	25180000	USD
CY2020Q4	orc	Net Interest Income NetInterestIncome	23882000	USD
CY2020Q2	orc	Portfolio Income PortfolioIncome	51528000	USD
CY2020Q3	orc	Portfolio Income PortfolioIncome	30925000	USD
CY2020Q1	orc	Management Fees ManagementFees	1724000	USD
CY2020Q2	orc	Management Fees ManagementFees	1616000	USD
CY2020Q3	orc	Management Fees ManagementFees	1629000	USD
CY2020Q4	orc	Management Fees ManagementFees	1826000	USD
CY2020Q1	us-gaap	Other Expenses OtherExpenses	417000	USD
CY2020Q2	us-gaap	Other Expenses OtherExpenses	1140000	USD
CY2020Q3	us-gaap	Other Expenses OtherExpenses	1220000	USD
CY2020Q4	us-gaap	Other Expenses OtherExpenses	972000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	2141000	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	2756000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	2849000	USD
CY2020Q4	us-gaap	Costs And Expenses CostsAndExpenses	2798000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-91199000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	48772000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	28076000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	16479000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.41
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.74
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.42
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.23
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.41
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.73
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2019Q2	orc	Interest Income InterestIncome	36455000	USD
CY2019Q3	orc	Interest Income InterestIncome	35907000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	3533000	USD
CY2019Q1	orc	Management Fees ManagementFees	1608000	USD
CY2019Q2	orc	Management Fees ManagementFees	1653000	USD
CY2019Q3	orc	Management Fees ManagementFees	1791000	USD
CY2019Q4	orc	Management Fees ManagementFees	1856000	USD
CY2019Q2	us-gaap	Other Expenses OtherExpenses	1168000	USD
CY2019Q3	us-gaap	Other Expenses OtherExpenses	841000	USD
CY2019Q4	us-gaap	Other Expenses OtherExpenses	880000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	2196000	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	2821000	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	2632000	USD
CY2019Q4	us-gaap	Costs And Expenses CostsAndExpenses	2736000	USD
CY2019Q1	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	18892000	USD
CY2019Q2	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	22431000	USD
CY2019Q3	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	22321000	USD
CY2019Q4	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	20022000	USD
CY2019Q1	orc	Net Interest Income NetInterestIncome	13541000	USD
CY2019Q3	orc	Net Interest Income NetInterestIncome	13586000	USD
CY2019Q4	orc	Net Interest Income NetInterestIncome	17507000	USD
CY2019Q1	orc	Realized And Unrealized Gains RealizedAndUnrealizedGains	-748000	USD
CY2019Q2	orc	Realized And Unrealized Gains RealizedAndUnrealizedGains	-7670000	USD
CY2019Q3	orc	Realized And Unrealized Gains RealizedAndUnrealizedGains	-19431000	USD
CY2019Q4	orc	Realized And Unrealized Gains RealizedAndUnrealizedGains	3841000	USD
CY2019Q1	orc	Portfolio Income PortfolioIncome	12793000	USD
CY2019Q2	orc	Portfolio Income PortfolioIncome	6354000	USD
CY2019Q3	orc	Portfolio Income PortfolioIncome	-5845000	USD
CY2019Q4	orc	Portfolio Income PortfolioIncome	21348000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-8477000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	18612000	USD
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.22
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.07
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.29
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48905000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	52601000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60419000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	63124000	shares

Files In Submission

Name	View Source	Status
0001518621-21-000030-index-headers.html	Edgar Link	pending
0001518621-21-000030-index.html	Edgar Link	pending
0001518621-21-000030.txt	Edgar Link	pending
0001518621-21-000030-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_000.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orc-20201231.xsd	Edgar Link	pending
orc-20201231_cal.xml	Edgar Link	unprocessable
orc-20201231_def.xml	Edgar Link	unprocessable
orc-20201231_lab.xml	Edgar Link	unprocessable
orc-20201231_pre.xml	Edgar Link	unprocessable
orc10k20201231.htm	Edgar Link	pending
orc10k20201231x211.htm	Edgar Link	pending
orc10k20201231x231.htm	Edgar Link	pending
orc10k20201231x311.htm	Edgar Link	pending
orc10k20201231x312.htm	Edgar Link	pending
orc10k20201231x321.htm	Edgar Link	pending
orc10k20201231x322.htm	Edgar Link	pending
orc10k20201231_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORC
Orchid Island Capital, Inc. Stock $orc

2021 Q1 Form 10-K Financial Statement

#000151862121000030 Filed on February 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORC Orchid Island Capital, Inc. Stock $orc

2021 Q1 Form 10-K Financial Statement

#000151862121000030 Filed on February 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORC
Orchid Island Capital, Inc. Stock $orc